Grannus Therapeutics

Indianapolis, IN · Founded 2020 · Privately Held (backing)

Operator of a pre-clinical stage biotechnology company intended to support a cancer treatment. Grannus Therapeutics is based in Indianapolis, IN and was founded in 2020. It was valued at $5 million at its seed round in Jan 2022, the last priced event on record. It has raised $2.9 million across 2 recorded rounds; the latest was an $800,000 debt round in Nov 2023.

PMV mark · valuation
$5.0M
Oct 2026
Priced at
its seed round
Jan 2022
Total raised
$2.9M
Last round
Debt
Nov 2023

Who backs Grannus Therapeutics?

7 investors
InvestorType
Plug and Play Tech Center—
Elevate VenturesVenture capital
1842 Fund—
Economic Development Corporation—
National Cancer Institute—
National Eye Institute—
Notre Dame Pit Road—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Grannus Therapeutics investors

7 investors are on record for Grannus Therapeutics, including Plug and Play Tech Center, Elevate Ventures, 1842 Fund and Economic Development Corporation. The debt round in Nov 2023 drew 9 investors.

Free account
More of Grannus Therapeutics with a free account
  • ·Watch Grannus Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Grannus Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View